# Cellceutix CORP — Form D

Cellceutix CORP of Beverly, MA, a company, filed a Form D exempt-offering notice with the SEC on 2012-05-10. The offering totals $1.0M, of which $100K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2012-05-10
- Form: D
- Accession: 0001355250-12-000025
- Industry: Biotechnology
- Exemptions: 06, 46
- Total offering: $1.0M
- Amount sold: $100K
- Remaining: $900K
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2012-05-08
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-177972

## Issuer

- Name: Cellceutix CORP
- CIK: 0001355250
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 100 Cumming Center, Beverly, MA, 01915
- Phone: (978)-633-3623

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Krishna Dr. Menon | Director | North Reading, PA |
| Leo Ehrlich | Director | Boca Raton, FL |
| Krishna Dr. Menon | Executive Officer | North Reading, PA |
| Leo Ehrlich | Executive Officer | Boca Raton, FL |
| Krishna Dr, Menon | Director | North Reading, MA |
| Krishna Dr, Menon | Executive Officer | North Reading, MA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2012-01-25](https://search.stillhousedata.com/formd/0001355250-12-000003) | D | $1.0M | $1.0M |
| [2012-01-25](https://search.stillhousedata.com/formd/0001355250-12-000004) | D/A | $1.0M | $1.0M |

## More

- [CIK 1355250 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1355250&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001355250-12-000025.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.
